ABSENCE OF RAPIDLY DEVELOPING RESISTANCE DURING TREATMENT OF CYSTIC-FIBROSIS PATIENTS WITH AZTREONAM

被引：4

作者：

ALLEN, JE

BOSSO, JA

SAXON, BA

MATSEN, JM

机构：

[1] UNIV UTAH,COLL PHARM,DEPT PHARM PRACTICE,SALT LAKE CITY,UT 84112

[2] UNIV UTAH,SCH MED,DEPT PEDIAT,SALT LAKE CITY,UT 84112

[3] UNIV UTAH,SCH MED,DEPT PATHOL,SALT LAKE CITY,UT 84112

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1987年 / 8卷 / 01期

关键词：

D O I：

10.1016/0732-8893(87)90047-2

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：51 / 55

页数：5

相关论文

共 9 条

[1] ARONOFF SC, 1984, ANTIMICROB AGENTS CH, V25, P279, DOI 10.1128/AAC.25.2.279
[2] EFFICACY OF AZTREONAM IN PULMONARY EXACERBATIONS OF CYSTIC-FIBROSIS
BOSSO, JA
BLACK, PG
MATSEN, JM
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (04) : 393 - 397
[3] INVITRO ACTIVITY OF AZTHREONAM, A MONOBACTAM ANTIBIOTIC
JACOBUS, NV
FERREIRA, MC
BARZA, M
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (05) : 832 - 838
[4] KRILOV LR, 1985, REV INFECT DIS, V7, pS482
[5] INVITRO ACTIVITIES OF RO 17-2301 AND AZTREONAM COMPARED WITH THOSE OF OTHER NEW BETA-LACTAM ANTIBIOTICS AGAINST CLINICAL ISOLATES OF PSEUDOMONAS-AERUGINOSA
NG, WWS
CHAU, PY
LEUNG, YK
LIVERMORE, DM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (05) : 872 - 873
[6] METHOD FOR RELIABLE DETERMINATION OF MINIMAL LETHAL ANTIBIOTIC CONCENTRATIONS
PEARSON, RD
STEIGBIGEL, RT
DAVIS, HT
CHAPMAN, SW
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (05) : 699 - 708
[7] SCULLY BE, 1985, REV INFECT DIS S4, V7, pS699
[8] EFFECT OF AZTREONAM IN COMBINATION WITH AZLOCILLIN OR PIPERACILLIN ON PSEUDOMONAS-AERUGINOSA
WU, DH
BALTCH, AL
SMITH, RP
CONLEY, PE
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (04) : 519 - 521
[9] 1985, M7A NAT COMM CLIN LA